Product/Composition:- | Penicillin V tablets |
---|---|
Strength:- | 250 mg, 500 mg |
Form:- | Tablets |
Reference Brands:- | Veetids, PenV, Penicillin VK(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Penicillin V inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. It effectively treats mild to moderate infections, such as tonsillitis, strep throat, and skin infections. Benefits include oral convenience, rapid bacterial eradication, and high safety when used appropriately, making it ideal for outpatient therapy.
Penicillin V tablets are approved in both the EU and US for treating streptococcal infections, including tonsillitis and skin infections. In the EU, brands like Penicillin VK are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, approval by the FDA is based on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for Penicillin V tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.